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Abstract
Nasopharyngeal aspirates were collected from 813 children £14 years old with acute lower respiratory tract infections in Lanzhou,
China, from December 2006 to November 2009. PCR or RT-PCR was used to screen for the presence of 10 respiratory viruses. Viral
agents were identiﬁed in 73.92% (601/813) of specimens, including RSV in 40.71%, hMPV in 6.15%, IFVA in 7.13%, IFVB in 0.98%, PIV1-3
in 7.87%, HCoV-HKU1 in 2.21%, HCoV-NL63 in 3.81%, HRV in 19.93%, AdV in 7.50% and HBoV in 11.56%. Two or more viruses were
detected in 34.44% (280/813) of cases. The newly identiﬁed respiratory viruses, HBoV, hMPV, HCoV-HKU1 and HCoV-NL63,
accounted for 22.01% of the detected viral pathogens. RSV and HRV were frequently detected in patients with bronchiolitis, and hMPV
was frequently associated with pneumonia. HCoV-NL63 was found to be one of the causative agents of acute respiratory wheezing in
young children. No seasonal variation was found in the incidence of detection of HCoV-HKU1, HCoV-NL63 or HBoV. This 3-year
study demonstrated that viral pathogens play an important role in children with ALRTIs, and more attention should be paid to these
newly identiﬁed viral agents.
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Introduction
Acute lower respiratory tract infections (ALRTIs) are the lead-
ing cause of morbidity and mortality in children worldwide,
with the greatest number of deaths occurring in developing
countries [1]. In China, pneumonia is the leading cause of death
in children under 5 years old (>30 000 per annum [2]). Viruses
account for 30–90% of ALRTIs in young children [3,4]. Respira-
tory syncytial virus (RSV), parainﬂuenza viruses (PIV1-3) and
inﬂuenza viruses A (IFVA) and B (IFVB) are the most common
viral agents responsible, being detected in 63.1% of Chinese
children hospitalized with acute respiratory infections [5].
However, many new respiratory viruses have recently been
identiﬁed as causative agents of lower respiratory illnesses in
children (e.g. human coronaviruses (HCoV)–NL63 and HCoV–
HKU1, human metapneumovirus (hMPV) and human bocavirus
(HBoV)) [6–8]. Moreover, rhinovirus (HRV), which has gener-
ally been considered a cause of mild upper respiratory illnesses
in children and adults, is now considered to be a major cause
of ALRTIs and asthmatic exacerbations [9,10]. However, these
viral agents of ALRTIs are rarely investigated or reported in
China. To further understand the epidemiology of ALRTIs in
children, we conducted a 3-year viral aetiology study to assess
the contribution of 10 respiratory viruses to childhood ALRTIs
in Lanzhou City, China.
Materials and Methods
Study participants and samples
From December 2006 to November 2009, nasopharyngeal
aspirates (NPAs) were collected from 813 children <14 years
of age who had been admitted to the First Hospital of Lanzhou
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University with ALRTIs on one ﬁxed day (Tuesday) per week.
ALRTIs were classiﬁed according to World Health Organiza-
tion deﬁnitions. Informed consent was obtained from the sub-
jects’ parents/guardians. The subjects’ age distribution was
10 days to 14 years (22.58 ± 28.20 months; mean ± SD), the
male:female ratio was 1.9:1, and the outpatient:inpatient ratio
was 1:3. The study protocol was approved by the hospital eth-
ics committee. NPAs collected from each subject were trans-
ported immediately to the laboratory at the National Institute
for Viral Disease Control and Prevention, China Centre for Dis-
ease Control, and stored at )80C until further processing.
RNA and DNA extraction
Viral DNA and RNA were extracted from 140 lL of each
NPA specimen using the QIAamp viral DNA and QIAamp
Viral RNA Mini kits (Qiagen, Shanghai, China) according to
the manufacturer’s instructions. cDNA was synthesized using
random hexamer primers with Superscript II RH-reverse
transcriptase (Invitrogen, Carlsbad, CA, USA).
Viral detection
Identiﬁcation of RSV, HRV, hMPV, IFVA, IFVB, HCoV-
HKU1, HCoV-NL63 and PIV1-3 viruses was performed by RT-
PCR using eight sets of primers [11,12]. Two sets of primers
were used to amplify AdV and HBoV DNA by PCR [13,14].
Statistical analysis
The statistical signiﬁcance of differences between groups was
compared using the chi-square or Fisher’s exact test;
p <0.05 was considered signiﬁcant.
Results
Respiratory virus prevalence
Of a total of 813 NPAs collected from December 2006 to
November 2009, 601(73.92%) were positive for at least one
respiratory virus (detection rates of 71.25%, 76.49% and
62.82% in the 2006–2007, 2007–2008 and 2008–2009 seasons,
respectively). In total, 877 positive PCR results were observed.
Co-infection with at least two types of virus was detected in
280 (46.59%) samples. The most frequently detected virus was
RSV (40.71%), followed by HRV (19.93%), HBoV (11.56%),
PIV1-3 (7.87%), AdV (7.50%), IFVA (7.13%), HMPV (6.15%),
NL63 (3.81%), HKU1 (2.21%) and IFVB (0.98%).
Patient characteristics
The male:female ratio of positive specimens was 1.8:1, but this
difference was not signiﬁcant (p 0.375; chi-square test). No
signiﬁcant effect of sex on the likelihood of isolation of any of
the seven viruses assayed was detected (Table 1; p 0.284; chi-
square test). The frequencies of virus detection in each of the
six age groups were 60.71%, 77.08%, 80.43%, 76.62%, 76.70%
and 61.94%, respectively (Table 2; p 0.001; chi-square test).
The highest frequency of viral isolation occurred in subjects
7–12 months of age. Signiﬁcant differences in the rate of RSV
infection among the six age groups were detected (p 0.000;
chi-square test). However, equivalent differences for AdV,
HRV, HMPV, PIV3, IFVA, IFVB, HKU1, NL63 and HBoV did
not reach signiﬁcance. RSV-associated ALTRIs predominated
in children <1 year old (Table 3).
Seasonal distribution
The seasonal distribution of respiratory virus detection is
shown in Fig. 1. During the study period, RSV, hMPV, PIV
and HRV showed a ﬁxed seasonal rhythm: the majority of
those viruses were detected from November to April. IFVA
also exhibited seasonal variation and reached a peak from
December 2008 to February 2009. Additionally, IFVA was
not detected after April 2009, a time when an H1N1 pan-
demic was occurring. Detection of IFVB was temporally scat-
tered, being isolated only during April and December 2007,
March 2008 and February 2009. Coronavirus HKU1 was also
mainly detected during the winter/spring months, with a peak
TABLE 1. Comparison of the characteristics of patients mono-infected with one of the six viruses
Characteristic
RSV
(n = 153)
hMPV
(n = 19)
HRV
(n = 59)
PIV1-3
(n = 20)
IFVA
(n = 14)
AdV
(n = 23)
HBoV
(n = 19) p
No. (%) of patients with coinfectiona 178 (55.78%) 31 (62%) 103 (63.59%) 44 (68.75%) 44 (75.86%) 38 (62.29%) 75 (79.79%) <0.01b,c
Age (months)
Median (range) 9 (0.03–144) 11 (0.58–108) 8 (0.2–132) 9.5 (0.6–96) 9 (0.03–168) 18 (0.03–108) 14.5 (0.1–108)
Sex
Male:female 94:59 13:6 33:26 12:8 7:7 19:4 14:5 >0.01c
Clinical diagnosis
Pneumonia 77 (50.3) 13 (68.4) 38 (61.0) 8 (40) 11 (78.6) 18 (78.3) 10 (52.6)
Bronchitis 8 (5.2) 1 (5.3) 1 (1.7) 4 (20) 3 (21.4) 1 (4.3) 4 (21.1)
Bronchiolitis 68 (44.4) 5 (26.3) 20 (33.9) 8 (40) 0 (0) 4 (17.4) 5 (26.3)
aEpisodes of coinfection with >1 virus were excluded from the analysis of demographic and clinical diagnosis.
bCoinfection rates of HBoV and IFVA were higher than those of RSV.
cCalculated using the Chi-square test.
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in January 2008. HCoV-Nl63 did not exhibit any noticeable
seasonal rhythm and was not detected during 2008; peak
detection occurred during July and October 2009. Notably,
HBoV was identiﬁed throughout each year of the study per-
iod, but exhibited a complex prevalence pattern. No seasonal
ﬂuctuation in HBoV prevalence was apparent from Decem-
ber 2006 to November 2008. However, a peak (56% of the
total isolates) was reached between December 2008 and
April 2009; after that, HBoV was not detected until Novem-
ber 2009. AdV was detected with a relatively constant fre-
quency throughout the study period, although no clear
seasonal distribution could be identiﬁed.
Clinical characteristics and co-infections
The clinical characteristics of 307 subjects in whom only one
virus was detected are summarized in Table 1 (HKU1, NL63
and IFVB were excluded from the analysis of demographic
and clinical characteristics because fewer than ﬁve subjects in
each group were infected with only one of these viruses).
The rate of co-infection (detection of more than one type of
virus in a single subject) among the six virus types exhibited
marked differences. HBoV showed the highest co-infection
rate; 79.8% (75/94) of HBoV-positive samples contained at
least one other virus, most commonly RSV (37 cases), fol-
lowed by HRV (21), ADV (12), IFVA (12), PIV3 (10), HMPV
(4), HKU1 (3) and NL63 (2). IFVA was more frequently
detected in patients with mixed viral infections (44/58 IFVA-
positive samples) than were the other viruses, with the
exception of HBoV.
Of the 49 HCoV-HKU1 and HCoV-NL63-positive sam-
ples, 36 (73.47%) were co-infected with at least one other
virus, most commonly HRV (14 cases) and RSV (11). Thirty-
one of 50 (62%) hMPV-positive samples were co-infected,
most frequently with RSV (data not shown).
Subjects who were positive for RSV, HRV, PIV1-3 and
AdV frequently suffered from pneumonia. RSV and HRV
were frequently detected in patients who were diagnosed
with bronchiolitis. Of the 31 NL63-positive subjects (data
not shown), 10 (32.26%) had experienced wheezing. The dif-
ference in the frequency of wheezing between subjects
infected with NL63 and RSV (35.95%) was not signiﬁcant
(chi-square test; p 0.685).
Discussion
ALRTIs are one of the most common paediatric diseases;
indeed, pneumonia is the main cause of death in children
under 5 years of age in developing countries [15]. In China,
24.5–65.2% of hospitalized paediatric patients are admitted
due to an ALRTI [16]. In this study, we evaluated the overall
prevalence of 10 respiratory viruses identiﬁed by PCR or
RT-PCR in children with ALRTIs from 2006 to 2009. Of the
813 samples collected, respiratory viruses were detected in
601 (73.92%), which is in agreement with other reports sug-
gesting that 30–90% of ALRTs have a viral aetiology [3,4,17].
However, the rate of respiratory virus detection in our
study was higher than in some other reports [5,18], which
may have been due to differences in detection methods.
Direct immunoﬂourescence and viral culture are the most
often applied methods; in contrast, we used RT-PCR and
PCR, which are highly sensitive [18]. Another possibility is
attempted detection of different viruses. Ten respiratory
viruses were included in this study, including the novel
TABLE 2. Number of positive specimens in different age
groups
Age, months
0–1 )6 )12 )36 )60 >60
Specimens
tested
112 192 138 201 103 67
No. of positive
specimens
68 148 111 154 79 41
% positive 60.71 77.08 80.43 76.6 2 76.70 61.94
TABLE 3. Frequency of virus isolation in children of different ages with ALRTIs
Age, months
)1 (%)
(n = 112)
)6 (%)
(n = 192)
)12 (%)
(n = 138)
)36 (%)
(n = 201)
)60 (%)
(n = 103)
>60 (%)
(n = 67) Total p value
RSV 27 (24.1) 101(52.6) 69 (50) 79 (39.3) 42 (40.8) 13 (19.4) 331 0.000
HRV 18 (16.1) 52 (27.1) 27 (19.6) 39 (19.4) 13 (12.6) 13 (19.4) 162 0.057
HMPV 2 (1.8) 14 (7.3) 10 (7.2) 10 (5.0) 10 (9.7) 4 (6.0) 50 0.207
PIV3 4 (3.6) 18 (9.4) 13 (9.4) 18 (9.0) 7 (6.8) 4 (6.0) 64 0.449
IFVA 9 (8.0) 14 (7.3) 9 (6.5) 17 (8.5) 5 (4.9) 4 (6.0) 58 0.889
IFVB 0 1 (0.5) 1 (0.7) 3 (1.5) 2 (1.9) 1 (1.5) 8 0.652
HKU1 3 (2.7) 4 (2.1) 4 (2.9) 4 (2.0) 0 3 (4.5) 18 0.495
NL63 0 7 (3.6) 6 (4.3) 11 (5.5) 3 (2.9) 4 (6.0) 31 0.210
AdV 4 (3.6) 9 (4.7) 11 (8.0) 18 (9.0) 12 (11.7) 7 (10.4) 61 0.120
HBoV 10 (8.9) 16 (8.3) 18 (13.0) 28 (13.9) 16 (15.5) 6 (9.0) 94 0.292
Total 77 236 168 227 110 59 877
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FIG. 1. Monthly occurrence of ALRTIs associated with 10 respiratory viruses isolated from children between 2006 and 2009.
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viruses HBoV, hMPV, HCoV-HKU1 and HCoV-NL63. Note
that seasonal differences in the rates of detection of respira-
tory viruses correlated with the occurrence of ALRTI epi-
demics (Fig. 1).
RSV was the most frequently detected respiratory virus
in children with ALRTIs in our study (40.71% of the ALRTIs
and 37.74% of total viral pathogens), in agreement with pre-
vious reports [19,20]. HRV has generally been considered a
cause of mild upper respiratory illnesses in children and
adults. However, HRV was second only to RSV in this study
and was detected in 19.93% of samples. This rate was simi-
lar to that reported by Juven et al. [21]. The annual inci-
dence of hMPV-associated ALRTIs was relatively stable
during the study period. This is not consistent with previ-
ous reports, which suggested that hMPV-associated ALRTIs
vary annually [18,22]. This suggests that hMPV may exhibit
geographically variable circulation patterns. Detection rates
of 0.7–8.8% for HCoV-NL63 and 1.6–6% for HCoV-HKU1
in children with acute respiratory tract infections have been
reported [18,23]. In this study, HCoV-NL63 and HCoV-
HKU1 accounted for 5.66% of the total cases, which sug-
gests that these viruses are important causes of ALRTIs in
children in Lanzhou City. The co-infection rate in HCoV-
NL63 and HCoV-HKU1-positive samples was 73.47% (36/
49) in this study, which is in line with previous reports
[23]. Since its discovery in 2005, HBoV has been frequently
detected worldwide in NPAs, with incidences varying from
1.5% to 18.9% [24–26]. The present study showed a rela-
tively high HBoV infection rate (11.56%) and a higher fre-
quency of co-infection (79.8%, 75/94) than the other viral
agents; RSV and HRV were most frequently detected in
conjunction with HBoV. Given this high co-infection rate,
the exact role of HBoV in ALRTIs needs to be investigated
further [18,27]. The newly identiﬁed respiratory viruses
(HBoV, hMPV, HCoV-NL63 and, HKU1) accounted for
22.01% of the total in this study. Thus these data suggest
that viral pathogens are important causes of ALRTIs in
Lanzhou City and that the novel respiratory viruses play an
important role in children with ALRTIs. The rate of mixed
infection, 46.59% (280/601), was signiﬁcantly higher than in
other reports (8.6–11.5%) [17,19], suggesting marked geo-
graphical variation. As to whether the mixed infection com-
pared with single infection with viruses may increase the
severity of disease, there have been some conﬂicting data.
In our study, due to limited clinical information, we can’t
reach a conclusion about this issue. Additional study is
needed to better deﬁne the role of mixed infection in the
severity of disease.
RSV, hMPV, PIV1-3 and HRV exhibited ﬁxed seasonal
epidemic patterns, but no seasonal variation was noted for
AdV, which is in agreement with most previous reports
[5,18,20]. Early reports suggested that epidemics of inﬂu-
enza occur in the winter months in temperate climates,
whereas inﬂuenza may be seen year-round in the tropics. In
our study, inﬂuenza occurred most frequently from Novem-
ber to April. However, inﬂuenza virus incidence did not
peak in 2009, the time of the H1N1 pandemic, suggesting
that the H1NI epidemic did not spread to Lanzhou City
prior to November 2009. Previous reports suggested that
HBoV infection occurred predominantly during the winter
season or that it increased in spring and summer [18,28].
In our study, HBoV was identiﬁed throughout each of the
ﬁrst 2 years of the study period, without any noticeable
seasonal ﬂuctuation. However, detection of this virus
peaked (56% of total isolates) between December 2008 and
April 2009, and then it was not detected again until
November 2009. This suggests that HBoV may exhibit a
geographically variable prevalence pattern. HCoV-NL63 and
HCoV-HKU1 have been in continuous circulation since they
were ﬁrst identiﬁed and cause numerous infections annually
[23]. In our study, HCoV-HKU1 was detected mainly during
winter and spring, with a peak in January 2008. However,
HCoV-Nl63 did not exhibit any ﬁxed seasonal rhythm;
indeed this virus was not detected in 2008 and peaked dur-
ing July and October 2009. HCoV-OC43 and HCoV-229E
predominantly circulate during the winter and early spring
with outbreaks occurring every 2–4 years [23]. Whether
HCoV-HKU1 and HCoV-Nl63 infections follow a similar
prevalence pattern is not clear. Thus, further study, and
particularly long-term surveillance, is needed to address
these issues.
Subjects 7–12 months of age showed the highest fre-
quency of viral detection. However, no signiﬁcant differ-
ences in infection rates in the six age groups for each viral
pathogen were detected, the sole exception being RSV
(Tables 2 and 3). RSV predominated in subjects <1 year of
age. This differs from other reports [18], which suggested
that RSV predominated among younger infants, but that
AdV, hMPV and IFVA were more frequently detected in
children over 24 months of age. Viral ALRTIs have been
suggested to occur more frequently in boys [17,29]. In this
study, although the male:female ratio of positive specimens
was 1.8:1, this was not signiﬁcant (p 0.375; chi-square test).
Further investigation is needed to elucidate the precise
effect of age and sex on the risk of viral infection in this
patient group.
RSV and HRV were frequently detected in patients with
bronchiolitis, and AdV and IFVA were common in subjects
with pneumonia. HBoV was more frequently observed in
those with pneumonia and bronchiolitis in this study,
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which suggests that HBoV is an important viral agent in
children with ALRTIs, as reported elsewhere [8,30].
HCoV-NL63 has been suggested to be a causative agent
of acute respiratory wheezing in young children [23]. In
this study, HCoV-NL63 patients also had a high frequency
of wheezing (32.26%), which was not signiﬁcantly different
from that of RSV (35.95%). Our data suggested that hMPV
was frequently associated with pneumonia, but other stud-
ies have suggested that hMPV is more often associated
with bronchiolitis or wheezy bronchitis [6]. Furthermore,
HRV is generally considered to be a common cause of
mild upper respiratory illnesses in children. However, here,
HRV was the most common viral pathogen in young
patients with ALRTIs. More data are needed to address
the exact clinical role of these newly identiﬁed respiratory
viruses.
As ALRTIs cause a high disease burden in China, strength-
ening research into the pathogens that cause these infections
is very important in developing new diagnostic and therapeu-
tic tools. This 3-year study demonstrated that at least three-
quarters of ALRTIs in children were associated with known
viral pathogens. RSV and HRV were the two most common
viruses detected. Novel viral agents, including HBoV, HCoV-
HKU1, HCoV-NL63 and hMPV, accounted for a high pro-
portion of ALRTIs. More attention should therefore be paid
to these agents. Additional study is required to deﬁne the
exact role and molecular and epidemiological characteristics
of these newly identiﬁed viral agents in ALRTIs in different
geographical regions.
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